BIOA
BioAge Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.59
+0.95%0
Insider buys (3m)
2
Insider sells (3m)
-$1.6M
Net value (3m)
-39.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 1, 2026 | Barton Shane · officer: Principal Accounting Officer | M-Exempt | 4,065 | $4.30 |
| Jul 1, 2026 | Barton Shane · officer: Principal Accounting Officer | M-Exempt | 4,000 | $8.39 |
| Jul 1, 2026 | Barton Shane · officer: Principal Accounting Officer | M-Exempt | 4,290 | $11 |
| Jul 1, 2026 | Barton Shane · officer: Principal Accounting Officer | Sale | 42,350 | $25 |
| Jul 1, 2026 | Barton Shane · officer: Principal Accounting Officer | M-Exempt | 9,301 | $11 |
| Jul 1, 2026 | Barton Shane · officer: Principal Accounting Officer | M-Exempt | 7,261 | $8.39 |
| Jul 1, 2026 | Barton Shane · officer: Principal Accounting Officer | M-Exempt | 8,958 | $4.30 |
| Jul 1, 2026 | Barton Shane · officer: Principal Accounting Officer | M-Exempt | 14,198 | $4.38 |
| Jul 1, 2026 | Barton Shane · officer: Principal Accounting Officer | Sale | 20,216 | $25 |
| Jul 1, 2026 | Barton Shane · officer: Principal Accounting Officer | M-Exempt | 7,861 | $4.38 |
| Jun 12, 2026 | Pande Vijay Satyanand · director | A-Award | 22,000 | $15 |
| Jun 12, 2026 | Hemrajani Rekha · director | A-Award | 22,000 | $15 |
| Jun 12, 2026 | HEALY JAMES · director | A-Award | 22,000 | $15 |
| Jun 12, 2026 | ENRIGHT PATRICK G · director | A-Award | 22,000 | $15 |
| Jun 12, 2026 | Davidson Michael H. · director | A-Award | 22,000 | $15 |
| Jun 12, 2026 | GARNIER JEAN PIERRE · director | A-Award | 22,000 | $15 |
| Apr 24, 2026 | GOLDSTEIN DOV A MD · officer: Chief Financial Officer | M-Exempt | 3,542 | $4.38 |
| Apr 3, 2026 | RUBIN PAUL D · officer: Chief Medical Officer | M-Exempt | 3,383 | $6.57 |
| Apr 3, 2026 | RUBIN PAUL D · officer: Chief Medical Officer | Sale | 8,820 | $18 |
| Apr 3, 2026 | RUBIN PAUL D · officer: Chief Medical Officer | M-Exempt | 5,437 | $4.11 |
| Feb 19, 2026 | RUBIN PAUL D · officer: Chief Medical Officer | A-Award | 110,000 | $20 |
| Feb 19, 2026 | Barton Shane · officer: Principal Accounting Officer | A-Award | 45,000 | $20 |
| Feb 19, 2026 | Morgen Eric · director, officer: Chief Operating Officer | A-Award | 110,000 | $20 |
| Feb 19, 2026 | Morgen Eric · director, officer: Chief Operating Officer | A-Award | 12,500 | $20 |
| Feb 19, 2026 | Fortney Kristen · director, officer: Chief Executive Officer | A-Award | 330,000 | $20 |
| Feb 19, 2026 | GOLDSTEIN DOV A MD · officer: Chief Financial Officer | A-Award | 110,000 | $20 |
| Feb 3, 2026 | GOLDSTEIN DOV A MD · officer: Chief Financial Officer | M-Exempt | 3,541 | $4.38 |
| Feb 3, 2026 | RUBIN PAUL D · officer: Chief Medical Officer | M-Exempt | 5,433 | $4.11 |
| Feb 3, 2026 | RUBIN PAUL D · officer: Chief Medical Officer | M-Exempt | 2,000 | $6.57 |
| Feb 3, 2026 | RUBIN PAUL D · officer: Chief Medical Officer | Sale | 7,433 | $19 |
Institutional positioning
13F filings over the trailing two quarters
New 77Increased 111Reduced 67Sold out 19
| Filer | Action | Shares | Filed |
|---|---|---|---|
| a16z Capital Management, L.L.C. | Unchanged | 3,233,170 | Aug 14, 2026 |
| AH CAPITAL MANAGEMENT, L.L.C. | Unchanged | 3,233,170 | May 15, 2026 |
| CORMORANT ASSET MANAGEMENT, LP | Increased | 2,890,605 | May 15, 2026 |
| BlackRock, Inc. | Increased | 2,849,077 | Aug 7, 2026 |
| Cormorant Asset Management, LP | Reduced | 2,390,605 | Aug 14, 2026 |
| Sofinnova Investments, Inc. | Unchanged | 2,293,788 | Aug 14, 2026 |
| SOFINNOVA INVESTMENTS, INC. | Unchanged | 2,293,788 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 2,267,756 | May 13, 2026 |
| Jupiter Topco LLC | New Position | 2,144,633 | Aug 14, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 2,094,270 | May 18, 2026 |
| OCTAGON CAPITAL ADVISORS LP | Increased | 1,748,000 | May 15, 2026 |
| Octagon Capital Advisors LP | Unchanged | 1,748,000 | Aug 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Increased | 1,671,648 | Aug 14, 2026 |
| MPM BioImpact LLC | New Position | 1,667,661 | Aug 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | New Position | 1,650,648 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 1, 2026